Bharat Biotech’s recombinant nasal vaccine for COVID-19 has been approved by Central Drugs Standard Control Organisation (CDSCO) for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation, Health Minister Mansukh Mandaviya tweeted on Tuesday.

“Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation,” Mr. Mandaviya tweeted.

This is the first intranasal vaccine for COVID-19 in the country.

The Minister further tweeted that this step will strengthen our collective fight against the pandemic. “India has harnessed its science, research and development, and human resources in the fight against COVID-19 under PM Narendra Modi’s leadership. With the science-driven approach and Sabka Prayas, we will defeat COVID-19.’’

source/content: thehindu.com (headline edited)